NCT00423046 2020-01-02Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of AgeGlaxoSmithKlinePhase 3 Completed1,106 enrolled 27 charts
NCT00492544 2018-09-04Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of AgeGlaxoSmithKlinePhase 3 Completed100 enrolled 9 charts